生物技术
Arrowhead Pharmaceuticals highlighted its ongoing transition toward commercial operations while maintaining a strong research and development core during a recent industry conference.
由 AI 报道
Daré Bioscience held its earnings call for the first quarter of 2026 on May 14 to discuss financial results and business updates focused on women's health products.
Researchers have boosted strawberry fruit quality by increasing activity of a housekeeping gene called FveIPT2. The modification raised levels of anthocyanins and terpenoids for richer color, aroma, and nutrition without affecting plant growth, fruit size, or sweetness. The findings, published in Horticulture Research, challenge views on basic cellular genes.
由 AI 报道
Adaptive Biotechnologies Corporation conducted its first quarter 2026 earnings conference call on May 5, 2026, at 4:30 PM EDT. Company executives, including CEO Chad Robins and CFO Kyle Piskel, presented financial results and forward-looking statements. The call is available via webcast on the company's investor relations website.
Inovio Pharmaceuticals reviews Q1 results and INO-3107 FDA status
May 14, 2026 00:03Pulse Biosciences presents ablation technology at healthcare conference
May 13, 2026 23:31Engineered E. coli produces natural sunscreen compound gadusol
May 12, 2026 16:47Engineered algae removes microplastics from water
May 12, 2026 13:13Verrica pharmaceuticals holds q1 2026 earnings call
May 01, 2026 03:57DNA hairpin molecules lowered cholesterol by 47% in mice by silencing PCSK9, researchers report
April 30, 2026 14:31Illumina holds Q1 2026 earnings call
April 30, 2026 12:13Scientists restore memory in Alzheimer's mice by blocking PTP1B
April 30, 2026 05:54Syntara reports positive FDA feedback on amsulostat trial
April 28, 2026 06:24University of Utah researchers identify enzyme PapB that can “lock” GLP-1-like peptides into ring structures